High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 studyPrognostic Study · 2011 · 435 citations
2. 2Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALLCohort Study · 2002 · 169 citations
3. 3Minimal Residual Disease in Acute Lymphoblastic LeukemiaClinical Trial · 2010 · 188 citations
4. 4Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detectionCohort Study · 2010 · 81 citations
5. 5Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cellsOriginal Research · 2009 · 1,117 citations